Antihypertensive drug prescription pattern before and during pregnancy in France

被引：4

作者：

Duhalde, Veronique ^{[1
]}

Delarue, Caroline ^{[1
]}

Lacroix, Isabelle ^{[1
]}

Suarez, Carole ^{[2
]}

Bourrel, Robert ^{[2
]}

Montastruc, Jean-Louis ^{[1
]}

Damase-Michel, Christine ^{[1
]}

机构：

[1] Univ Toulouse, Fac Med, Lab Pharmacol Med & Clin, Unite Pharmacoepidemiol,EA 3696, F-31000 Toulouse, France

[2] Caisse Reg Assurance Malad Midi Pyrenees, F-31065 Toulouse 9, France

来源：

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH | 2011年 / 1卷 / 02期

关键词：

Antihypertensive drug; Pregnancy; Women; Foetotoxicity; RECEPTOR ANTAGONISTS; MEDICATION USE; ANGIOTENSIN; HYPERTENSION; EXPOSURE;

D O I：

10.1016/j.preghy.2011.01.001

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Objective: This study provides firsthand information on antihypertensive prescriptions before and during pregnancy in France. Methods: The study, on 23,898 women, was carried out using data from the French Health Insurance System. Results: Before and during pregnancy, 1.1% and 5.1% of women received prescriptions for antihypertensive drugs: beta blockers and diuretics before, and nifedipine, nicardipine, labetalol and methyldopa during pregnancy. Sixty-six pregnant women were exposed to angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Conclusion: Pregnant women still receive prescriptions for harmful drugs. In order to prevent such exposures, it should be recommended to avoid these prescriptions in women of child-bearing age who plan to be pregnant. (C) 2011 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

引用

页码：185 / 189

页数：5

共 27 条

[1]

Abalos E, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002252.pub2, 10.1002/14651858.CD002252.pub3]

[2] Use of calcium channel antagonists for preterm labor [J].

Ables, AZ ;

Romero, AM ;

Chauhan, SP .

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2005, 32 (03) :519-+

[3] Pharmacological treatment of hypertension in pregnancy [J].

Afifi, Y ;

Churchill, D .

CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (21) :1745-1753

[4]

AFSSAPS, 2008, RAPP CONTR IND ANT R

[5]

AFSSAPS, 2003, RAPP CONTR IND ANT R

[6]

*AFSSAPS, 2002, POUSS HYP AD EL TENS

[7]

AFSSAPS, 2008, REC DEUX CLASS MED A

[8] Angiotensin II receptor antagonist treatment during pregnancy [J].

Alwan, S ;

Polifka, JE ;

Friedman, JM .

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2005, 73 (02) :123-130

[9] Outpatient use of cardiovascular drugs during pregnancy [J].

Andrade, Susan E. ;

Raebel, Marsha A. ;

Brown, Jeffrey ;

Lane, Kimberly ;

Livingston, James ;

Boudreau, Denise ;

Rolnick, Sharon J. ;

Roblin, Douglas ;

Smith, David H. ;

Dal Pan, Gerald J. ;

Scott, Pamela E. ;

Platt, Richard .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (03) :240-247

[10] Fetal toxic effects of angiotensin II receptor antagonists: Case report and follow-up after birth [J].

Bos-Thompson, MA ;

Hillaire-Buys, D ;

Muller, F ;

Dechaud, H ;

Mazurier, E ;

Boulot, P ;

Morin, D .

ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) :157-161

← 1 2 3 →